Miltenyi Biotec Clinimacs Formulation Solution Has Been Developed For Ex Vivo Cell Based Drug Product

Miltenyi Biotec CliniMACS® Formulation Solution is intended as excipient for processing of human cells from heterogeneous cell populations in combination with the CliniMACS Prodigy® System. The Formulation Solution consists of a salt solution which is already supplemented with 2.5% human serum albumin (HSA). | CliniMACS Cryo Supplement, 3× is intended as excipient together with the CliniMACS Formulation Solution for processing of human cells from heterogeneous cell populations in combination with the CliniMACS Prodigy® System. The Cryo Supplement 3× consists of a sugar solution containing 22.5% DMSO. In combination with the CliniMACS Formulation Solution the Cryo Supplement 3× serves as a freezing solution with 7.5% DMSO final concentration. Both products are provided as ready-to-use solutions in bags and can be sterile welded onto tubes of a CliniMACS Prodigy Tubing Set. | | - MLTY (Additional S&H or Hazmat Fees May Apply)